SCHEMBL25980334

SCHEMBL25980334

c1ccc(-c2ccc(N(c3ccccc3)c3cccc4c3oc3cc(-c5cccc(-c6nc(-c7ccccc7)nc(-c7ccccc7)n6)c5)ccc34)cc2)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.34
TSHR P16473 3/20 0.34
POLB P06746 2/20 0.34
LMNA P02545 2/20 0.34
KMT2A Q03164 2/20 0.34
HTT P42858 1/20 0.34
ALDH1A1 P00352 4/20 0.33
KDM4E B2RXH2 2/20 0.33
ABCG2 Q9UNQ0 1/20 0.33
MMP12 P39900 1/20 0.32
MMP13 P45452 1/20 0.32
KDM1A O60341 1/20 0.32
HPGD P15428 3/20 0.32
PDE5A O76074 2/20 0.32
CYP1A2 P05177 1/20 0.32
GLA P06280 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25980258 1.00 MAPT (0.34) MAPTTSHRPOLBLMNAKMT2A
SCHEMBL25979998 0.98 MAPT (0.35) MAPTTSHRPOLBLMNAKMT2A
SCHEMBL25980276 0.98 MAPT (0.35) MAPTTSHRPOLBLMNAKMT2A
SCHEMBL25980061 0.98 MAPT (0.35) MAPTTSHRPOLBLMNAKMT2A
SCHEMBL25980318 0.98 MAPT (0.35) MAPTTSHRPOLBLMNAKMT2A
SCHEMBL25980257 0.98 MAPT (0.35) MAPTTSHRPOLBLMNAKMT2A
SCHEMBL25979706 0.97 MAPT (0.38) MAPTTSHRPOLBLMNAKMT2A
SCHEMBL25980060 0.96 MAPT (0.35) MAPTTSHRPOLBLMNAKMT2A
SCHEMBL25980335 0.95 MAPT (0.38) MAPTTSHRPOLBLMNAKMT2A
SCHEMBL25979977 0.95 MAPT (0.36) MAPTTSHRPOLBLMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-11-16 US disclosed
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-11-16 US disclosed
EP-4227301-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT Materials Co., Ltd. (KR) 2023-08-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, CYP1A1, CYP1B1 MAPT 1428/4885TSHR 4037/4885POLB 2906/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.